# A pocket-sized tube-feeding pump with FDA clearance gets $25 million to reach more patients at home - Published: 2026-11-10 - Author: [Healthcare News](https://healthcarenews.io/author/healthcarenews-io.md) - Topics: [News](https://healthcarenews.io/news.md) - About: [Luminoah](https://luminoah.com/), [Luminoah Flow](https://luminoah.com/luminoah-flow/) - Based on: [Luminoah Raises $25 Million Series B to Expand Access to Its FDA-Cleared Enteral Feeding System](https://www.globenewswire.com/news-release/2026/11/10/3399278/0/en/luminoah-raises-25-million-series-b-to-expand-access-to-its-fda-cleared-enteral-feeding-system.html), GlobeNewswire, 2026-11-10 - Based on: [510(k) K253558: Luminoah FLOW Enteral Nutrition System](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K253558), U.S. Food and Drug Administration - Based on: [Prevalence of Home Parenteral and Enteral Nutrition in the United States](https://pubmed.ncbi.nlm.nih.gov/28715295/), Nutrition in Clinical Practice - Based on: [LCD L38955: Enteral Nutrition](https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=38955), Centers for Medicare & Medicaid Services - Based on: [Luminoah](https://luminoah.com/), Luminoah - Source: https://healthcarenews.io/news/portable-enteral-feeding-pump-luminoah-series-b/ - Publication: Healthcare News - Publisher: Connectively (Terkel, Inc.) - Editorial policy: https://healthcarenews.io/editorial-policy/ - AI use: Connectively's automated system wrote this article with AI from a press release issued by Luminoah on November 10, 2026, linked under Sources. Statements about the company and its products are the company's. The illustration was generated with AI. The article was assembled and published automatically, without an editor's review. Report errors to corrections@connectively.us. Luminoah, the Charlottesville, Virginia maker of an FDA-cleared portable enteral feeding pump, said on November 10, 2026, that it has raised a $25 million Series B led by Sandbox Clinical Ventures. The money is meant to get its pocket-sized Luminoah Flow system to more home medical equipment suppliers and health systems across the US. ## Key points - The round combines $20 million of new equity with $5 million of earlier convertible notes that converted into it, Luminoah says. - GV, Sands Capital, the Blue Venture Fund, the Texas Medical Center Venture Fund, the CU Healthcare Innovation Fund and the American Gastroenterological Association GI Opportunity Fund also invested, alongside existing backers. - The FDA cleared the Luminoah FLOW Enteral Nutrition System on April 20, 2026, under 510(k) number K253558, according to the [FDA's 510(k) database](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K253558). - After clearance, the company says, it completed an early access program with patients of healthcare institutions in the Pacific Northwest and the Southeast. ## How many people in the US are fed by tube at home? Several hundred thousand. A Mayo Clinic team estimated that 437,882 people in the US received home enteral nutrition in 2013, the year their study measured, of whom 189,036 were children and 248,846 adults, and found its prevalence had risen sharply since 1992, using Medicare data and figures from large home infusion providers ([Mundi et al., Nutrition in Clinical Practice, 2017](https://pubmed.ncbi.nlm.nih.gov/28715295/)). Luminoah says the equipment those patients rely on has barely changed in decades: conventional pumps often have to be carried on poles, caregivers keep much of the record in handwritten feeding logs, and clinicians have little view of how much nutrition actually reaches the patient. ## What is the Luminoah Flow portable enteral feeding pump? It is a three-part system: a pocket-sized, rechargeable pump, nutrition pouches and a connected mobile app, according to the company. Luminoah says patients can feed while going about their day, their feeding activity uploads to the app, and, if a patient opts to share it, clinicians can see delivered nutrition on the company's Luminoah Intelligence platform. The [FDA's clearance record](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K253558) files the device under the enteral infusion pump product code, through the 510(k) premarket notification pathway. > "For too long, families who depend on tube feeding have had to organize their lives around the pump. We built Luminoah so the technology could fit around their lives instead." > > — Neal Piper, Founder and Chief Executive Officer, Luminoah ## What will the $25 million pay for? Three things, the company says: wider distribution of Luminoah Flow through home medical equipment (HME) suppliers and health systems in the US, more manufacturing capacity with added automation, and further work on the clinician-facing Luminoah Intelligence platform. It is also hiring in commercial, operations and engineering roles. | The round | Detail | |---|---| | Size | $25 million Series B | | Made up of | $20 million new equity and $5 million of converted notes | | Lead investor | Sandbox Clinical Ventures | | Other investors | Blue Venture Fund, GV, Sands Capital, Texas Medical Center Venture Fund, CU Healthcare Innovation Fund, AGA GI Opportunity Fund, existing investors | | Product | Luminoah Flow, [cleared by the FDA on April 20, 2026 (K253558)](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K253558) | | Uses | Distribution, manufacturing capacity, Luminoah Intelligence | > "Reaching thousands of patients takes distribution partners, manufacturing at scale, and software clinicians will actually use. Our Series B financing enables us to focus on these key initiatives." > > — Garrett Marin, Chief Operating Officer, Luminoah ## What does this mean for care teams and suppliers? Our analysis: most of this round is pointed at getting the device to patients rather than at building it. Luminoah names HME suppliers and health systems as the next channels for Flow, with manufacturing scale behind them. The investor list points the same way. Alongside venture firms it includes the Blue Venture Fund, part of a group of funds the release describes as owned by participating Blue Cross Blue Shield companies, a fund tied to the Texas Medical Center, and the American Gastroenterological Association's own fund: an insurer-backed investor, a medical-center investor and a gastroenterology society on one cap table. For HME suppliers, any enteral pump billed to Medicare falls under existing rules. Medicare's [Enteral Nutrition local coverage determination, L38955](https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=38955), covers a pump, billed as B9002, when the medical record documents why syringe or gravity feeding is not enough, with examples such as reflux or aspiration, a feeding rate under 100 ml an hour, or feeding through a gastrostomy or jejunostomy tube. For dietitians and gastroenterology teams, the opt-in data feed is the part that changes daily practice, since it offers a record of delivered nutrition in place of the handwritten logs the company describes. Readers following home monitoring tools may also want our coverage of [nurse-led medication tracking in a remote patient monitoring app](https://healthcarenews.io/news/rpm-healthcare-launches-medication-tracking-feature-with-nurse-led-support-in-rpm365-patie/) and of [round-the-clock support for family caregivers](https://healthcarenews.io/news/during-national-family-caregivers-month-caregivercompanion-ai-offers-free-24-7-support-to/). ## Frequently asked questions ### Who led Luminoah's Series B? Sandbox Clinical Ventures, an Austin-based fund that invests in medical devices, diagnostics and clinical AI, led the round. ### When did the FDA clear Luminoah Flow? On April 20, 2026, under [510(k) number K253558](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K253558), listed by the FDA as the Luminoah FLOW Enteral Nutrition System. ### Can a clinician see a patient's feeding data? Only if the patient chooses to share it, Luminoah says; clinicians then review delivered nutrition on the Luminoah Intelligence platform. ### Where is Luminoah based, and when was it founded? The company was founded in 2020 and is headquartered in Charlottesville, Virginia. ## Sources - [Luminoah Raises $25 Million Series B to Expand Access to Its FDA-Cleared Enteral Feeding System](https://www.globenewswire.com/news-release/2026/11/10/3399278/0/en/luminoah-raises-25-million-series-b-to-expand-access-to-its-fda-cleared-enteral-feeding-system.html): press release from Luminoah via GlobeNewswire, 10 November 2026. - [510(k) K253558, Luminoah FLOW Enteral Nutrition System](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K253558): the clearance record in the FDA's premarket notification database. - [Prevalence of Home Parenteral and Enteral Nutrition in the United States](https://pubmed.ncbi.nlm.nih.gov/28715295/): Mundi MS and colleagues, Nutrition in Clinical Practice, 2017, on PubMed. - [LCD L38955, Enteral Nutrition](https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=38955): Medicare's local coverage determination for enteral nutrition, in the CMS Medicare Coverage Database. - [Luminoah](https://luminoah.com/): the company's website.